Metropolitan Life Insurance Company (MetLife)’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-5,066
| Closed | -$334K | – | 2463 |
|
|
2023
Q1 | $334K | Sell |
5,066
-697
| -12% | -$46K | 0.02% | 523 |
|
|
2022
Q4 | $298K | Buy |
5,763
+131
| +2% | +$6.77K | 0.01% | 570 |
|
|
2022
Q3 | $385K | Buy |
5,632
+150
| +3% | +$10.2K | 0.02% | 518 |
|
|
2022
Q2 | $248K | Buy |
5,482
+588
| +12% | +$26.6K | 0.01% | 631 |
|
|
2022
Q1 | $249K | Sell |
4,894
-13,512
| -73% | -$687K | 0.01% | 716 |
|
|
2021
Q4 | $870K | Buy |
18,406
+749
| +4% | +$35.4K | 0.01% | 1063 |
|
|
2021
Q3 | $582K | Buy |
17,657
+291
| +2% | +$9.59K | 0.01% | 1355 |
|
|
2021
Q2 | $1.1M | Buy |
17,366
+1,073
| +7% | +$67.8K | 0.02% | 938 |
|
|
2021
Q1 | $699K | Sell |
16,293
-860
| -5% | -$36.9K | 0.01% | 1199 |
|
|
2020
Q4 | $981K | Sell |
17,153
-1,187
| -6% | -$67.9K | 0.01% | 895 |
|
|
2020
Q3 | $553K | Hold |
18,340
| – | – | 0.01% | 1151 |
|
|
2020
Q2 | $599K | Buy |
18,340
+134
| +0.7% | +$4.38K | 0.01% | 1071 |
|
|
2020
Q1 | $488K | Buy |
18,206
+2,076
| +13% | +$55.6K | 0.01% | 1058 |
|
|
2019
Q4 | $494K | Hold |
16,130
| – | – | 0.01% | 1333 |
|
|
2019
Q3 | $389K | Buy |
16,130
+3,071
| +24% | +$74K | 0.01% | 1446 |
|
|
2019
Q2 | $331K | Buy |
13,059
+843
| +7% | +$21.4K | 0.01% | 1557 |
|
|
2019
Q1 | $238K | Hold |
12,216
| – | – | ﹤0.01% | 1781 |
|
|
2018
Q4 | $161K | Hold |
12,216
| – | – | ﹤0.01% | 1945 |
|
|
2018
Q3 | $217K | Buy |
+12,216
| New | +$217K | ﹤0.01% | 1950 |
|
|
2018
Q2 | – | Sell |
-4,020
| Closed | -$88.9K | – | 2449 |
|
|
2018
Q1 | $88.9K | Buy |
+4,020
| New | +$88.9K | ﹤0.01% | 2343 |
|